Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies
Although hypomethylating agents (HMA) have revolutionised the treatment of myelodysplastic syndromes (MDS), a significant proportion of patients either fail to respond to HMA or their disease progresses after an initial response. Established therapeutic options for these patients remain limited. For...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2018-08-01
|
| Series: | European Medical Journal Hematology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/hematology/article/therapeutic-options-in-myelodysplastic-syndromes-established-and-emerging-therapies/ |